{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:00:04Z","timestamp":1781830804790,"version":"3.54.5"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/inf.0000000000000930","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T03:13:33Z","timestamp":1442978013000},"page":"81-93","source":"Crossref","is-referenced-by-count":23,"title":["Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines After Coadministration"],"prefix":"10.1097","volume":"35","author":[{"given":"Roberto","family":"Gasparini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Tregnaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavitra","family":"Keshavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Ypma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Smolenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210202","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease.","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"RR-2","key":"R5-19-20210202","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","article-title":"Global practices of meningococcal vaccine use and impact on invasive disease.","volume":"108","author":"Ali","year":"2014","journal-title":"Pathog Glob Health"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tmaid.2014.04.011","article-title":"Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study.","volume":"12","author":"Alberer","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jtm.12180","article-title":"Immunogenicity and safety of concomitant administration of a combined hepatitis AB vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults.","volume":"22","author":"Alberer","year":"2015","journal-title":"J Travel Med"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jtm.12164","article-title":"Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.","volume":"22","author":"Alberer","year":"2015","journal-title":"J Travel Med"},{"key":"R12-19-20210202","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2010.02.045","article-title":"Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.","volume":"28","author":"Arguedas","year":"2010","journal-title":"Vaccine"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/CVI.00436-09","article-title":"Randomized trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis vaccine in adolescents and young adults.","volume":"17","author":"Gasparini","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R14-19-20210202","first-page":"231","article-title":"Immunogenicity and safety of combined tetanus, reduced diphtheria, acellular pertussis vaccine when co-administered with quadrivalent meningococcal conjugate and human papillomavirus vaccines in healthy adolescents.","volume":"5","author":"Gasparini","year":"2014","journal-title":"J Vaccines Vaccin"},{"key":"R15-19-20210202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/INF.0b013e31823dce5c","article-title":"Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants.","volume":"31","author":"Klein","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R16-19-20210202","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.vaccine.2012.03.080","article-title":"Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers.","volume":"30","author":"Klein","year":"2012","journal-title":"Vaccine"},{"key":"R17-19-20210202","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4161\/hv.27051","article-title":"Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age.","volume":"10","author":"Nolan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R18-19-20210202","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijid.2014.03.1390","article-title":"Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers.","volume":"26","author":"Tregnaghi","year":"2014","journal-title":"Int J Infect Dis"},{"key":"R21-19-20210202","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.vaccine.2014.07.088","article-title":"Effect of multiple, simultaneous vaccines on polio seroresponse and associated health outcomes.","volume":"33","author":"Broderick","year":"2015","journal-title":"Vaccine"},{"key":"R22-19-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jadohealth.2004.02.021","article-title":"Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds.","volume":"36","author":"Cassidy","year":"2005","journal-title":"J Adolesc Health"},{"key":"R24-19-20210202","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.vaccine.2004.08.030","article-title":"Booster vaccination with hexavalent DTPa-HBV-IPVHib vaccine in the second year of life is as safe as concomitant DTPa-IPVHib HBV administered separately.","volume":"23","author":"Saenger","year":"2005","journal-title":"Vaccine"},{"key":"R27-19-20210202","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.vaccine.2008.11.036","article-title":"Brighton Collaboration Methods Working Group. Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies.","volume":"27","author":"Bonhoeffer","year":"2009","journal-title":"Vaccine"},{"key":"R29-19-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/10543400600719251","article-title":"Statistical considerations for noninferiorityequivalence trials in vaccine development.","volume":"16","author":"Wang","year":"2006","journal-title":"J Biopharm Stat"},{"key":"R31-19-20210202","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/CVI.00414-13","article-title":"Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPVHib vaccine administered at 3, 5, and 12 months of age.","volume":"20","author":"Vesikari","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"R32-19-20210202","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"R34-19-20210202","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/CVI.00437-10","article-title":"Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine.","volume":"18","author":"Vesikari","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R35-19-20210202","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4161\/hv.20212","article-title":"The investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) and the seasonal influenza virus vaccine are immunogenic and well-tolerated when co-administered in adults.","volume":"8","author":"Aplasca-De Los Reyes","year":"2012","journal-title":"Hum Vaccin Immunother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:08:50Z","timestamp":1620954530000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201601000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000930","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}